These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 11757723)

  • 121. Intensive retreatment of adults and children with acute lymphoblastic leukemia.
    Bassan R; Cornelli PE; Battista R; Terzi F; Buelli M; Rambaldi A; Viero P; D'Emilio A; Dini E; Barbui T
    Hematol Oncol; 1992; 10(2):105-10. PubMed ID: 1592360
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Hassan IB; Kristensen J; Alizadeh H; Bernsen R
    Med Oncol; 2013 Jun; 30(2):519. PubMed ID: 23468219
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Primary ocular recurrence of leukemia following bone marrow transplant.
    Sahdev I; Weinblatt ME; Lester H; Finger PT; Kochen J
    Pediatr Hematol Oncol; 1993; 10(3):279-82. PubMed ID: 8217546
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study.
    Chin CK; Lim KJ; Lewis K; Jain P; Qing Y; Feng L; Cheah CY; Seymour JF; Ritchie D; Burbury K; Tam CS; Fowler NH; Fayad LE; Westin JR; Neelapu SS; Hagemeister FB; Samaniego F; Flowers CR; Nastoupil LJ; Dickinson MJ
    Br J Haematol; 2020 Dec; 191(5):806-815. PubMed ID: 33065767
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
    Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
    Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
    [TBL] [Abstract][Full Text] [Related]  

  • 126. [Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
    Sun XF; Zhen ZJ; Liu DG; Xia ZJ; Huang HQ; Zhang L; Zhou ZM; Li YH; Xia Y; Ling JY; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):58-61. PubMed ID: 17575697
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD.
    Damlaj M; Snnallah M; Bashir R; Eddine IS; Alahmari B; Salama H; Alaskar A; Alhejazi A; Alzahrani M
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):690-696. PubMed ID: 32636149
    [TBL] [Abstract][Full Text] [Related]  

  • 128. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
    Freedman AS; Gribben JG; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Pandite L; Robertson MJ; Kroon M; Ritz J; Nadler LM
    Blood; 1996 Oct; 88(7):2780-6. PubMed ID: 8839876
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
    Hoskins PJ; Le N; Gascoyne RD; Klasa R; Shenkier T; O'Reilly S; Connors JM
    Ann Oncol; 1997 Nov; 8(11):1125-32. PubMed ID: 9426332
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation.
    Lin YW; Hamahata K; Watanabe K; Adachi S; Akiyama Y; Kubota M; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):86-9. PubMed ID: 11530811
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Rossi MR; Masera G; Zurlo MG; Amadori S; Mandelli F; Bagnulo S; Carli M; Zanesco L; Dini G; Guazzelli C
    Pediatr Hematol Oncol; 1986; 3(1):1-9. PubMed ID: 3153213
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
    Ramanujachar R; Richards S; Hann I; Goldstone A; Mitchell C; Vora A; Rowe J; Webb D
    Pediatr Blood Cancer; 2007 Mar; 48(3):254-61. PubMed ID: 16421910
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
    Olivieri A; Santini G; Patti C; Chisesi T; De Souza C; Rubagotti A; Aversa S; Billio A; Porcellini A; Candela M; Centurioni R; Congiu AM; Brunori M; Nati S; Spriano M; Vimercati R; Marino G; Contu A; Tedeschi L; Majolino I; Crugnola M; Sertoli MR;
    Ann Oncol; 2005 Dec; 16(12):1941-8. PubMed ID: 16157621
    [TBL] [Abstract][Full Text] [Related]  

  • 134. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 135. The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.
    Broccoli A; Argnani L; Gugliotta G; Pellegrini C; Casadei B; Bagnato G; Gentilini M; Stefoni V; Zinzani PL
    Oncologist; 2024 Jun; 29(6):e789-e795. PubMed ID: 38339976
    [TBL] [Abstract][Full Text] [Related]  

  • 136. High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.
    Kozlowski P; Åström M; Ahlberg L; Bernell P; Hulegårdh E; Hägglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Hallböök H
    Haematologica; 2012 Sep; 97(9):1414-21. PubMed ID: 22511497
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.
    Aricò M; Valsecchi MG; Conter V; Rizzari C; Pession A; Messina C; Barisone E; Poggi V; De Rossi G; Locatelli F; Micalizzi MC; Basso G; Masera G
    Blood; 2002 Jul; 100(2):420-6. PubMed ID: 12091331
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis.
    Tachibana T; Kanda J; Ishizaki T; Najima Y; Tanaka M; Doki N; Fujiwara SI; Kimura SI; Onizuka M; Takahashi S; Saito T; Mori T; Fujisawa S; Sakaida E; Miyazaki T; Aotsuka N; Gotoh M; Watanabe R; Shono K; Kanamori H; Kanda Y; Okamoto S;
    Ann Hematol; 2021 Nov; 100(11):2763-2771. PubMed ID: 34357435
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    Shimizu H; Kikuchi M; Takaue Y; Utsumi J; Takeda T; Fujimoto T
    Int J Hematol; 1995 Feb; 61(2):85-96. PubMed ID: 7734716
    [TBL] [Abstract][Full Text] [Related]  

  • 140. True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Soslow RA; Davis RE; Warnke RA; Cleary ML; Kamel OW
    Blood; 1996 Jun; 87(12):5207-12. PubMed ID: 8652834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.